Clinical Trials · NCT05813912
A Research Study to See How a New Weekly Insulin, Insulin Icodec When Given Along With Semaglutide Helps in Reducing the Blood Sugar Level in Patients With Type 2 Diabetes
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 148
- Start date
- Sep 2023
- Locations
- 39 sites, 5 countries
- Primary endpoint
- Change in Glycated Haemoglobin (HbA1c)